Catalyst Wire Dossier Catalyst Wire Dossier

Ficlatuzumab

ficlatuzumab
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Ficlatuzumab, covering 2015-07-29 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma [Phase 3]

See pricing